Cytex Founding Scientists Receive Top Award in Orthopaedic Research

The American Academy of Orthopedic Surgeons (AAOS) today announced that the 2021 Kappa Delta Elizabeth Winston Lanier Award has been granted to Cytex Therapeutics founders Drs. Farshid Guilak, Bradley Estes and Frank Moutos. The Kappa Delta Awards recognize research in musculoskeletal disease or injury with potential to advance patient care and are the highest awards in the field of […]

Continue reading


Cytex Showcases to NIH Investor Forum

 Cytex was pleased to participate in the Life Sciences Showcase Conference, hosted virtually by the National Institutes of Health.  This Conference, held in November 2020, is a leading forum for early stage innovators to present their companies to potential partners and investors.  Cytex President and COO Bradley Estes, PhD., gave a virtual presentation on the […]

Continue reading


Cytex Awarded CRP Award for First-In-Human Pilot Trial

Cytex is thrilled to announce the receipt of a Commercialization Readiness Pilot Program Award from the National Institute of Health entitled “Cartilage Regeneration with Tunable Inflammation Resistance.”  The goal of this project is to prepare for and then conduct a First-In-Human pilot clinical trial that will test the safety of Cytex’s innovative hip implant.  Cytex is grateful […]

Continue reading


Cytex CEO Presents at Med Tech conference

Cytex Therapeutics was pleased to be a feature presenter at the November 2019 MedTech Innovation Conference in San Francisco.  This annual conference features invited speakers from leading global medical device companies, as well as institutional and Venture Capital investors in the Med Tech space.  The purpose of this conference is to provide an opportunity for […]

Continue reading